Skip to main content

Gabor Marth, D.Sc.

Languages spoken: English, Hungarian

Academic Information

Departments: Human Genetics - Professor

Academic Office Information

George and Dolores Eccles Institute of Human Genetics
Human Genetics
15 N 2030 E, Room: 7410B
Salt Lake City, UT 84112


Dr. Marth is Professor of Human Genetics and Co-Director of the Utah Center for Genetic Discovery at University of Utah Health Sciences Center. He is an internationally recognized expert in the analysis of DNA sequence variations. Dr. Marth and his group played a key role in the development of methods and software that support the use of high-throughput sequencing technologies to study DNA variation on large scale, and led the design of standardized formats (SAM/BAM, VCF) that have now been widely adopted by the genomics community as the common currency for storing genomic sequencing data. Dr. Marth and his laboratory are currently at the forefront of developing computational algorithms for precision oncology: tracking cancer patients’ tumors as they progress across chemo-resistance, relapse, and metastasis; and using advanced genomic, tumor modeling, and drug screening approaches for personalized cancer treatment. As part of NHGRI’s Undiagnosed Disease Network, Dr. Marth and his team develop computational algorithms for discovering the genetic causes of common and rare diseases, and a comprehensive web tool system for rare disease diagnostics. He serves as Principal Investigator on academic and small-business research projects funded by the National Human Genome Research Institute, the National Cancer Institute, the National Center for Advancing Translational Sciences, the Simons Foundation, the Margolis Family Foundation, and the Utah Science Technology and Research Initiative. Dr. Marth is leading the Genomics of Advanced and Complex Cancers Initiative, and organizes the Single Cell Genomics working group at the University of Utah and Huntsman Cancer Institute. He serves on the Scientific Advisory Boards of the Ontario Institute of Cancer Research Adaptive Oncology Program, Canada’s Genomic Enterprise, and the Galaxy Project. Dr. Marth is co-founder and Chief Scientific Officer of Frameshift Genomics, Inc., a technology startup company building web tools for genomic data management and visual analytics.

Education History

Fellowship Washington University School of Medicine
Postdoctoral Research Associate
Doctoral Training Washington University
Systems Science and Mathematics
Postdoctoral Fellowship Hungarian Academy of Science
Postdoctoral Fellow
Undergraduate Technical University of Budapest
Electrical Engineering
B.S., M.S.

Global Impact


Date Role Description Country
06/01/2014 Scientific Advisory Board Chair, Scientific Advisory Board, Computational Biology Program, Ontario Institute for Cancer Research Global